Exelixis (EXEL) Change in Receivables (2010 - 2026)

Exelixis (EXEL) recorded quarterly Change in Receivables of $42.0 million in Q2 2026, up 284.27% quarter-over-quarter from -$22.8 million in Q1 2026, and up 160.75% on a YoY basis from $16.1 million in Q2 2025.

Exelixis (EXEL) Change in Receivables (2010 - 2026) Analysis & Trends

Exelixis' Change in Receivables history runs 17 years deep, the most recent figure standing at $42.0 million for Q2 2026.

  • In Q2 2026, Change in Receivables rose 160.75% year-over-year to $42.0 million; the TTM figure through Apr 2026 stood at $47.3 million (up 15.68% YoY), while the FY2026 annual figure was $21.4 million, down 23.44% from the prior year.
  • Change in Receivables was $42.0 million for Q2 2026 at Exelixis, up from -$22.8 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $156.0 million in Q2 2024 to a low of -$127.0 million in Q3 2024.
  • Historically, Change in Receivables has averaged $2.8 million across 5 years, with a median of $3.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Change in Receivables tumbled 27370.73% in 2023, then jumped 18223.93% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $41000.0 in 2022, then sank by 27370.73% to -$11.2 million in 2023, then tumbled by 1036.08% to -$127.0 million in 2024, then soared by 113.67% to $17.4 million in 2025, then jumped by 141.97% to $42.0 million in 2026.
  • The last three Change in Receivables figures came in at $42.0 million (Q2 2026), -$22.8 million (Q1 2026), and $17.4 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 22,529.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -39.80 Mn
9 Abivax 95.45 Bn 95.45 Bn - -4.08 Mn
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn 42.03 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 42.03 Mn
Apr 3, 2026 42.03 Mn
Jan 2, 2026 -22.81 Mn
Jan 2, 2026 -22.81 Mn
Oct 3, 2025 17.37 Mn
Oct 3, 2025 17.37 Mn
Jul 4, 2025 10.72 Mn
Jul 4, 2025 10.72 Mn
Apr 4, 2025 16.12 Mn
Apr 4, 2025 16.12 Mn
Jan 3, 2025 -4.24 Mn
Jan 3, 2025 -4.24 Mn
Sep 27, 2024 -127.03 Mn
Sep 27, 2024 -127.03 Mn
Jun 28, 2024 156.05 Mn
Jun 28, 2024 156.05 Mn
Mar 29, 2024 3.17 Mn
Mar 29, 2024 3.17 Mn
Dec 29, 2023 -11.18 Mn
Dec 29, 2023 -11.18 Mn